Lv5
848 积分 2025-07-14 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5个月前
已完结
β-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancer
5个月前
已完结
Malignant peripheral nerve sheath tumour (MPNST) of the cervix: differential diagnosis and a favourable oncological outcome with multimodality treatment
9个月前
已完结
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect
10个月前
已完结
Metabonomic Studies of Human Hepatocellular Carcinoma Using High-Resolution Magic-Angle Spinning 1H NMR Spectroscopy in Conjunction with Multivariate Data Analysis
11个月前
已完结
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
1年前
已完结
Gene editing to induce FOXP3 expression in human CD4 + T cells leads to a stable regulatory phenotype and function
1年前
已完结
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
1年前
已完结
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
10个月前
已采纳
In vivo chimeric antigen receptor (CAR)-T cell therapy
10个月前
已采纳
In vivo chimeric antigen receptor(CAR)-T cell therapy
10个月前
已采纳
When metabolism met immunology
10个月前
已采纳
Dual-payload ADCs move into first oncology clinical trials
11个月前
已采纳
Dual-payload ADCs move into first oncology clinical trials
11个月前
已采纳
In vivo CAR T cells gain traction, with AbbVie’s US$2.1 billion acquisition of Capstan Therapeutics
11个月前
已采纳
From one to many gene therapies
11个月前
已采纳
Quadruplex nucleic acids as targets for anticancer therapeutics
1年前
已采纳
Reversible ALKBH5 cytosolic aggregation accelerates cellular senescence
1年前
已采纳
皖公网安备34019202002308
